Abstract:The expanding field of site-specific ligation of proteins and peptides has catalyzed the development of novel methods that enhance molecular modification. Among these methods, enzymatic strategies have emerged as dominant due to their specificity and efficiency in modifying proteins under mild conditions. Asparaginyl endopeptidase is a group of cyclotide-producing cysteine proteases from plants. These plant cysteine proteases, known for their specificity, effectively recognize the tripeptide motif (Asx-Xaa-Yaa) and cleave at the C-terminal side of Asx residues, forming acyl-enzyme intermediates that facilitate transpeptidation. Butelase 1 stands out as the most efficient AEP for protein engineering, yet challenges in its expression and purification limit its accessibility for widespread research and industrial use. To address these challenges, we engineered a new, catalytically efficient variant of Butelase 1, Butelase AY, by mutating the gatekeeping residues Val237Ala and Thr238Tyr within the LAD-1 region. These modifications significantly enhanced the stability and yield of Butelase AY, allowing for successful application in various peptide and protein engineering tasks. Butelase AY was tested on the peptide GLGKY, the globular protein GFP, and the intrinsically disordered protein α-synuclein, effectively labeling them with a fluorescent probe. Notably, Butelase AY maintained its efficiency with substrates containing unnatural amino acids, making it a promising candidate for biorthogonal applications. Importantly, the mutations did not compromise the enzyme's specificity, as it continued to process model peptides and native protein substrates with N-term NHV recognition motifs effectively. In conclusion, Butelase AY presents a novel recombinant tool for diverse protein labeling and modifications, particularly in biorthogonal strategies. This innovation has the potential to expand applications in biotechnology and therapeutic development, ultimately revolutionizing protein engineering and its utility in synthetic biology.

Construction, expression and functional characterization of the β-lactamase with αv integrin ligands.

Development of a β-lactamase activity assay for detecting ligand-protein interactions using an engineered split intein and β-lactamase

Functional expression and purification of bovine enterokinase light chain in recombinant Escherichia coli.

Engineering protein theranostics using bio-orthogonal asparaginyl peptide ligases

Expression and Functional Characterization of a Recombinant Targeted Toxin with an Upa Cleavable Linker in Pichia Pastoris.

EGFR-targeting, β-defensin-tailored fusion protein exhibits high therapeutic efficacy against EGFR-expressed human carcinoma via mitochondria-mediated apoptosis

The Construction of Anti-EGFR Single Chain Variable Fragment Fused with Gelonin Toxin Prokaryotic Expressing Plasmid and the Study of Its Anti-tumor Effects

Synthesis and purification of a toxin-linked conjugate targeting epidermal growth factor receptor in Escherichia coli.

An EGF Receptor-Targeting Amphinase Recombinant Protein Mediates Anti-Tumor Activity in Vitro and in Vivo

An uPA cleavable conjugate of a recombinant αvβ3 targeting toxin and its bioactivity

Prediction and Prokaryotic Expression of the Mutual Epitope from All Plasmid-mediated AmpC Β-Lactamases

Prokaryotic Expression, Purification and Biological Activity of β-Lactamase TEM-1

Mechanism of proton transfer in class A -lactamase catalysis and inhibition by avibactam

An engineered prodrug selectively suppresses β-lactam resistant bacteria in a mixed microbial setting

Design and Construction of an Effective Expression System with Aldehyde Tag for Site-Specific Enzyme Immobilization

The Development of Activatable Lytic Peptides for Targeting Triple Negative Breast Cancer

Single-step Enzymatic Glycoengineering for the Construction of Antibody-cell Conjugates

A β-Lactamase Responsive Peptide Inhibits MRSA Infection through Self-Assembled Nanonet

An efficient and easily obtainable butelase variant for chemoenzymatic ligation and modification of peptides and proteins

[Stable Expression and Characterization of the Von Willebrand Factor Cleaving Protease].

Platform to Discover Protease-Activated Antibiotics and Application to Siderophore-Antibiotic Conjugates